SCHEMBL4832006

SCHEMBL4832006

CCCCCCCCCCCCc1ccc(S(=O)(=O)ON2C(=O)C3C(C2=O)C2C(=O)N(OS(=O)(=O)c4ccc(CCCCCCCCCCCC)cc4)C(=O)C32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.50
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
F2 P00734 1/20 0.46
MAPT P10636 1/20 0.46
VDR P11473 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
FAAH O00519 1/20 0.43
MGLL Q99685 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA9 Q16790 1/20 0.42
FUT7 Q11130 1/20 0.42
ESR1 P03372 2/20 0.41
ADRA2A P08913 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
TACR2 P21452 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826381 0.92 CA2 (0.46) CA2KDM4EALDH1A1F2MAPT
SCHEMBL4827289 0.88 CA2 (0.47) CA2KDM4EALDH1A1F2MAPT
SCHEMBL4834719 0.83 ALDH1A1 (0.64) CA2KDM4EALDH1A1F2MAPT
SCHEMBL14569432 0.79 PARL (0.55) CA2KDM4EALDH1A1F2MAPT
SCHEMBL2323376 0.78 CA2 (0.64) CA2KDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL11589672 0.78 CA2 (0.64) CA2KDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL4831824 0.77 CA2 (0.49) CA2KDM4EALDH1A1SMN1; SMN2FAAH
SCHEMBL1089319 0.77 KDM4E (0.65) CA2KDM4EALDH1A1F2MAPT
SCHEMBL4248939 0.76 CA2 (0.62) CA2KDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL18531403 0.76 CA2 (0.62) CA2KDM4EALDH1A1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 CA2 1249/4885KDM4E 2501/4885ALDH1A1 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.